Jim Anthony

Jim Anthony is Chief Commercial Officer (COO) and President, Parexel Biotech. In this role he oversees both biotech and pharmaceutical customer strategy and relationships globally, leveraging the company’s comprehensive suite of solutions and industry-leading therapeutic expertise across Phase I-IV clinical development to accelerate and advance their life-changing therapies to market. 

He joined Parexel in 2010 as Vice President, North America Business Development, and since that time has held various leadership roles of increasing responsibility, including Corporate Vice President, Enterprise Account Leader, where he directly managed two of the company’s largest pharma customers, and Executive Vice President and Global Head, Parexel Biotech, before being appointed as President and Global Head, Parexel Biotech in 2023. 

Jim has more than 25 years of pharmaceutical development and CRO experience, including positions with Kendle International (now Syneos Health) and SCIREX Corporation (now Premier Research). In 2022, he was recognized as a PharmaVoice 100 award recipient, a prestigious accolade that recognizes the 100 most-inspiring individuals in the life sciences sector. 

Jim holds a Bachelor of Arts degree from Columbia University (NY) and a Master of Business Administration degree from the University of Cincinnati.